← Browse by Condition
Medical Condition
primary immune thrombocytopenia itp
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 1
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Enrollment
69 pts
Location
United States, Austr...
Sponsor
argenx
NCT06880081 Phase 1
Recruiting
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Enrollment
12 pts
Location
China
Sponsor
Chongqing Peg-Bio Biopharm Co....
NCT05338190 Phase 3
Recruiting
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
Enrollment
132 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...